Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-β
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-β ; volume:7 ; number:1 ; day:17 ; month:10 ; year:2017 ; pages:1-7 ; date:12.2017
Scientific reports ; 7, Heft 1 (17.10.2017), 1-7, 12.2017
- Urheber
-
Lee, Jin San
Park, Seongbeom
Kim, Hee Jin
Kim, Yeshin
Jang, Hyemin
Kim, Ko Woon
Rhee, Hak Young
Yoon, Sung Sang
Hwang, Kyoung Jin
Park, Key-Chung
Moon, Seung Hwan
Kim, Sung Tae
Lockhart, Samuel N.
Na, Duk L.
Seo, Sang Won
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-13370-8
- URN
-
urn:nbn:de:101:1-2019051218495063991379
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jin San
- Park, Seongbeom
- Kim, Hee Jin
- Kim, Yeshin
- Jang, Hyemin
- Kim, Ko Woon
- Rhee, Hak Young
- Yoon, Sung Sang
- Hwang, Kyoung Jin
- Park, Key-Chung
- Moon, Seung Hwan
- Kim, Sung Tae
- Lockhart, Samuel N.
- Na, Duk L.
- Seo, Sang Won
- SpringerLink (Online service)
Ähnliche Objekte (12)
Origins of amyloid-β
Selective amyloid-β lowering agents
![Development of conformation specific Amyloid-β [Amyloid-beta] antibodies](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
Endovascular coil visible in a visible vessel
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Copper mediated amyloid-β binding to Transthyretin
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Consequences of Amyloid‐β Deficiency for the Liver
Effects of anle138b treatment on amyloid-β neurotoxicity
Origins of amyloid-β
Selective amyloid-β lowering agents
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
Endovascular coil visible in a visible vessel
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Copper mediated amyloid-β binding to Transthyretin
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Consequences of Amyloid‐β Deficiency for the Liver
Effects of anle138b treatment on amyloid-β neurotoxicity
Origins of amyloid-β
Selective amyloid-β lowering agents
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery
Endovascular coil visible in a visible vessel
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Copper mediated amyloid-β binding to Transthyretin
Amyloid-β 1–24 C-terminal truncated fragment promotes amyloid-β 1–42 aggregate formation in the healthy brain
Corynoxine isomers decrease levels of amyloid-β peptide and amyloid-β precursor protein by promoting autophagy and lysosome biogenesis
Rationally Designed Peptoid Inhibitors of Amyloid‐β Oligomerization
Consequences of Amyloid‐β Deficiency for the Liver